Moti Hacham
Directeur Général chez Spero Biopharma Ltd.
Profil
Mordechai Saar Hacham is currently the Chief Executive Officer & Director at Spero Biopharma Ltd., Chief Financial Officer at OncoHost Ltd., and a Member of the Israel Bar Association.
He previously served as the Chief Executive Officer at Clal Life Sciences (CLS) LP, Vice President-Operations at Polyheal Ltd., Chief Operating & Financial Officer at CureTech Ltd., and Chief Operating & Financial Officer at Avraham Pharmaceuticals Ltd.
He also held a Principal position at Check Point Software Technologies Ltd.
and served as a Director at Scopus Biopharma, Inc. from 2021 to 2022.
Mr. Hacham received his undergraduate degree from Tel-Aviv University and his graduate degree from Bar-Ilan University.
Postes actifs de Moti Hacham
| Sociétés | Poste | Début |
|---|---|---|
Israel Bar Association
 Israel Bar Association Miscellaneous Commercial ServicesCommercial Services Israel Bar Association is a private company headquartered in Tel Aviv, Israel. The firm provides legal services. | Corporate Officer/Principal | - |
Spero Biopharma Ltd.
 Spero Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Spero Biopharma Ltd. develops ladostigil an treatment for mild cognitive impairment. The company was founded by Marta Weinstock-Rosin and is headquartered in Tel Aviv-Yafo, Israel. | Directeur Général | - |
OncoHost Ltd.
 OncoHost Ltd. Miscellaneous Commercial ServicesCommercial Services OncoHost Ltd. is an Israeli technology company that combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of cancer therapy. The company utilizes proprietary proteomic analysis to understand a patient's unique response to therapy and overcome resistance to therapy. OncoHost's host response profiling platform (Prophet®) analyzes proteomic changes in blood samples to monitor the dynamics of biological processes induced by the patient in response to a given cancer therapy. OncoHost was founded in 2017, and the CEO is Ofer Sharon. | Directeur Financier/CFO | - |
Anciens postes connus de Moti Hacham
| Sociétés | Poste | Fin |
|---|---|---|
| SCOPUS BIOPHARMA INC. | Directeur/Membre du Conseil | 26/04/2022 |
Clal Life Sciences (CLS) LP
 Clal Life Sciences (CLS) LP Investment ManagersFinance Part of Clal Biotechnology Industries Ltd., Clal Life Sciences (CLS) LP is a venture capital fund. | Directeur Général | - |
Avraham Pharmaceuticals Ltd.
 Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel. | Directeur Financier/CFO | - |
| CHECK POINT SOFTWARE TECHNOLOGIES LTD. | Corporate Officer/Principal | - |
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Directeur Financier/CFO | - |
Formation de Moti Hacham
| Tel-Aviv University | Undergraduate Degree |
| Bar-Ilan University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CHECK POINT SOFTWARE TECHNOLOGIES LTD. | Technology Services |
| SCOPUS BIOPHARMA INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Polyheal Ltd.
 Polyheal Ltd. Pharmaceuticals: MajorHealth Technology Polyheal Ltd. provides wound healing products. The company was founded by Vladimir Ritter and Dov Reichman in 1996 and is headquartered in Yavne, Israel. | Health Technology |
Israel Bar Association
Israel Bar Association Miscellaneous Commercial ServicesCommercial Services Israel Bar Association is a private company headquartered in Tel Aviv, Israel. The firm provides legal services. | Commercial Services |
CureTech Ltd.
CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Health Technology |
Clal Life Sciences (CLS) LP
Clal Life Sciences (CLS) LP Investment ManagersFinance Part of Clal Biotechnology Industries Ltd., Clal Life Sciences (CLS) LP is a venture capital fund. | Finance |
Avraham Pharmaceuticals Ltd.
Avraham Pharmaceuticals Ltd. BiotechnologyHealth Technology Avraham Pharmaceuticals Ltd. develops pharmaceutical products for prevention and treatment of neurodegenerative disorders. Its lead product candidate, Ladostigil is designed to provide treatment for Mild Cognitive Impairment. The firm’s product candidate is a multifunctional compound that combines neuroprotective mechanisms: reducing oxidative stress and microglial activation, and inhibiting proinflamtory cytokines. The company was founded in 2010 by David Warshawsky and is headquartered in Yavneh, Israel. | Health Technology |
OncoHost Ltd.
OncoHost Ltd. Miscellaneous Commercial ServicesCommercial Services OncoHost Ltd. is an Israeli technology company that combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of cancer therapy. The company utilizes proprietary proteomic analysis to understand a patient's unique response to therapy and overcome resistance to therapy. OncoHost's host response profiling platform (Prophet®) analyzes proteomic changes in blood samples to monitor the dynamics of biological processes induced by the patient in response to a given cancer therapy. OncoHost was founded in 2017, and the CEO is Ofer Sharon. | Commercial Services |
Spero Biopharma Ltd.
Spero Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Spero Biopharma Ltd. develops ladostigil an treatment for mild cognitive impairment. The company was founded by Marta Weinstock-Rosin and is headquartered in Tel Aviv-Yafo, Israel. | Health Technology |
